Literature DB >> 27197171

MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin.

Rosemary O'Brien1, Sieu L Tran1, Michelle F Maritz1, Bing Liu1, Cheng Fei Kong1, Stefania Purgato2, Chen Yang1, Jayne Murray1, Amanda J Russell1, Claudia L Flemming1, Georg von Jonquieres1, Hilda A Pickett3, Wendy B London4, Michelle Haber1, Preethi H Gunaratne5, Murray D Norris1, Giovanni Perini2, Jamie I Fletcher1, Karen L MacKenzie6.   

Abstract

The RNA-binding protein dyskerin, encoded by the DKC1 gene, functions as a core component of the telomerase holoenzyme as well as ribonuclear protein complexes involved in RNA processing and ribosome biogenesis. The diverse roles of dyskerin across many facets of RNA biology implicate its potential contribution to malignancy. In this study, we examined the expression and function of dyskerin in neuroblastoma. We show that DKC1 mRNA levels were elevated relative to normal cells across a panel of 15 neuroblastoma cell lines, where both N-Myc and c-Myc directly targeted the DKC1 promoter. Upregulation of MYCN was shown to dramatically increase DKC1 expression. In two independent neuroblastoma patient cohorts, high DKC1 expression correlated strongly with poor event-free and overall survival (P < 0.0001), independently of established prognostic factors. RNAi-mediated depletion of dyskerin inhibited neuroblastoma cell proliferation, including cells immortalized via the telomerase-independent ALT mechanism. Furthermore, dyskerin attenuation impaired anchorage-independent proliferation and tumor growth. Overexpression of the telomerase RNA component, hTR, demonstrated that this proliferative impairment was not a consequence of telomerase suppression. Instead, ribosomal stress, evidenced by depletion of small nucleolar RNAs and nuclear dispersal of ribosomal proteins, was the likely cause of the proliferative impairment in dyskerin-depleted cells. Accordingly, dyskerin suppression caused p53-dependent G1 cell-cycle arrest in p53 wild-type cells, and a p53-independent pathway impaired proliferation in cells with p53 dysfunction. Together, our findings highlight dyskerin as a new therapeutic target in neuroblastoma with crucial telomerase-independent functions and broader implications for the spectrum of malignancies driven by MYC family oncogenes. Cancer Res; 76(12); 3604-17. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197171     DOI: 10.1158/0008-5472.CAN-15-0879

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Pseudouridine as a novel biomarker in prostate cancer.

Authors:  Jennifer A Stockert; Rachel Weil; Kamlesh K Yadav; Natasha Kyprianou; Ashutosh K Tewari
Journal:  Urol Oncol       Date:  2020-07-22       Impact factor: 3.498

2.  Exosomes from human adipose-derived mesenchymal stromal/stem cells accelerate angiogenesis in wound healing: implication of the EGR-1/lncRNA-SENCR/DKC1/VEGF-A axis.

Authors:  Yang Sun; Yikun Ju; Bairong Fang
Journal:  Hum Cell       Date:  2022-06-25       Impact factor: 4.374

3.  Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma.

Authors:  Ruida Hou; Ying Yu; Madison N Sluter; Lexiao Li; Jiukuan Hao; Jie Fang; Jun Yang; Jianxiong Jiang
Journal:  Cell Rep       Date:  2022-06-21       Impact factor: 9.995

4.  MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.

Authors:  Javier A Baena-Del Valle; Qizhi Zheng; David M Esopi; Michael Rubenstein; Gretchen K Hubbard; Maria C Moncaliano; Andrew Hruszkewycz; Ajay Vaghasia; Srinivasan Yegnasubramanian; Sarah J Wheelan; Alan K Meeker; Christopher M Heaphy; Mindy K Graham; Angelo M De Marzo
Journal:  J Pathol       Date:  2017-11-14       Impact factor: 7.996

5.  Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion.

Authors:  Fa-An Miao; Kun Chu; Hai-Rong Chen; Meng Zhang; Pei-Cong Shi; Jin Bai; Yong-Ping You
Journal:  Invest New Drugs       Date:  2019-03-07       Impact factor: 3.850

Review 6.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

7.  TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer.

Authors:  Xiaoting Jia; Zhijie Zhang; Kai Luo; Guopei Zheng; Minying Lu; Ying Song; Hao Liu; Huisi Qiu; Zhimin He
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

8.  Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma.

Authors:  Jessica L Bell; Sven Hagemann; Jessica K Holien; Tao Liu; Zsuzsanna Nagy; Johannes H Schulte; Danny Misiak; Stefan Hüttelmaier
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

9.  SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival.

Authors:  Hexiu Su; Juncheng Hu; Liang Huang; Yang Yang; Morgan Thenoz; Anna Kuchmiy; Yufeng Hu; Peng Li; Hui Feng; Yu Zhou; Tom Taghon; Pieter Van Vlierberghe; Guoliang Qing; Zhichao Chen; Hudan Liu
Journal:  Nat Commun       Date:  2018-10-15       Impact factor: 14.919

10.  A new role for human dyskerin in vesicular trafficking.

Authors:  Nunzia Di Maio; Rosario Vicidomini; Alberto Angrisani; Valentina Belli; Maria Furia; Mimmo Turano
Journal:  FEBS Open Bio       Date:  2017-09-12       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.